Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results